[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-338977-en":59,"doc-seo-338977-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":19,"preview_urls":81},338977,962075006959,"Anda","https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Prediction for oxaliplatin-induced liver injury using patient-derived liver organoids","Oxaliplatin (L-OHP)-based chemotherapy for colorectal cancer liver metastases can cause clinically important liver injury, especially when combined with surgery, yet no definitive biomarker reliably predicts individual risk. This study evaluated whether patient-derived liver organoids can forecast L-OHP-induced liver toxicity. Organoids were generated from noncancerous liver tissues from 10 patients treated with L-OHP-based chemotherapy and hepatectomy, then tested in vitro by relating organoid responses to clinical injury signs.","DOI: 10. 1002/cam4 .7042  \nRESEAR CH ARTICLE  \nPrediction for oxaliplatin-induced liver injury using patient-derived liver organoids  \nKumiko Tatsumi1,2  | Hiroshi Wada3 | Shinichiro Hasegawa3 | Kei Asukai3 | Shigenori Nagata4 | Tomoya Ekawa1 | Takashi Akazawa1  | Yu Mizote1  | Shintaro Okumura2  | Ryosuke Okamura2 | Masayuki Ohue3 | Kazutaka Obama2 | Hideaki Tahara1,5  \n1Department of Cancer Drug Discovery and Development, Research Center, Osaka International Cancer Institute, Osaka, Japan  \n2Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan  \n3Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan 4Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan 5Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan  \nCorrespondence  \nShintaro Okumura, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 ShogoinKawahara-cho, Sakyo-ku, Kyoto 606- 8507, Japan.  \nEmail: [sokumura@kuhp.kyoto-u.ac.jp](sokumura@kuhp.kyoto-u.ac.jp)  \nFunding information  \nOsaka International Cancer Institute; Japan Agency for Medical Research and Development, Grant/Award Number: 22ak0101187h0101  \nAbstract  \nBackground: Liver injury associated with oxaliplatin (L-OHP)-based chemotherapy can significantly impact the treatment outcomes of patients with colorectal cancer liver metastases, especially when combined with surgery. To date, no definitive biomarker that can predict the risk of liver injury has been identified. This study aimed to investigate whether organoids can be used as tools to predict the risk of liver injury.  \nMethods: We examined the relationship between the clinical signs of L-OHPinduced liver injury and the responses of patient-derived liver organoids in vitro. Organoids were established from noncancerous liver tissues obtained from 10 patients who underwent L-OHP-based chemotherapy and hepatectomy for colorectal cancer.  \nResults: Organoids cultured in a galactose differentiation medium, which can activate the mitochondria of organoids, showed sensitivity to L-OHP cytotoxicity, which was significantly related to clinical liver toxicity induced by L-OHP treatment. Organoids from patients who presented with a high-grade liver injury to the L-OHP regimen showed an obvious increase in mitochondrial superoxide levels and a significant decrease in mitochondrial membrane potential with L-OHP exposure. L-OHP-induced mitochondrial oxidative stress was not observed in the organoids from patients with low-grade liver injury.  \nConclusions: These results suggested that L-OHP-induced liver injury may becaused by mitochondrial oxidative damage. Furthermore, patient-derived liver organoids may be used to assess susceptibility to L-OHP-induced liver injury in individual patients.  \nKEYWORDS  \nliver injury, organoids, oxaliplatin, oxidative stress, sinusoidal obstruction syndrome  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine. 2024;13:e7042 .  \n[https://doi.org/10.1002/cam4.7042](https://doi.org/10.1002/cam4.7042)  \n[wileyonlinelibrary.com/journal/cam4](wileyonlinelibrary.com/journal/cam4)  \n1 of 14  \n1 | INTRODUCTION  \nOxaliplatin (L-OHP)-based regimens are the current standard chemotherapy for metastatic colorectal cancer. Pharmacotherapy with cancer drugs, including L-OHP, prolongs the overall survival of patients diagnosed with unresectable advanced metastatic colorectal cancer and may also allow curative resection for metastatic lesions.1,2 For resectable liver metastases, L-OHP may be administered as perioperative chemotherapy for patients at high risk of recurrence or incomplete resection. Despite its th","cbCaiuG5xzKhK603","https://ap.wps.com/l/cbCaiuG5xzKhK603","pdf",12600630,14,"English","en",105,"# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Clinical impact and need for biomarkers\n## Existing biomarker evidence and limitations\n## Rationale for patient-derived organoids","[{\"question\":\"What problem does the study address regarding oxaliplatin treatment?\",\"answer\":\"L-OHP-based chemotherapy can lead to liver injury that affects treatment outcomes, but accurate and reliable biomarkers to predict who is at risk have not been established.\"},{\"question\":\"How were the patient-derived liver organoids used in this study?\",\"answer\":\"Organoids were established from noncancerous liver tissues from 10 patients who received L-OHP-based chemotherapy and hepatectomy, and their in vitro responses were compared with clinical signs of liver injury.\"},{\"question\":\"What key biological findings linked organoid responses to clinical liver toxicity?\",\"answer\":\"Organoids from patients with high-grade liver injury showed increased mitochondrial superoxide levels and decreased mitochondrial membrane potential after L-OHP exposure, whereas oxidative stress was not observed in organoids from low-grade injury patients.\"}]","Prediction for oxaliplatin-induced liver injury using patient-derived liver organoids | PDF",1790026992,35,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f2dfe6f2265681a503e81b21c6d3394.webp",983,1291,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de58cb09eb92bcb0d52c370b278823c8.webp",982,1290,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e80e92c082a8034006c01530c2b5752b.webp",981,1289,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a83e7dc8c153236d112e134d7aa3b061.webp",980,1287,{"code":4,"msg":100,"data":101},"ok",{"site_id":75,"language":74,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"prediction-for-oxaliplatin-induced-liver-injury-using-patient-derived-liver-organoids","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/prediction-for-oxaliplatin-induced-liver-injury-using-patient-derived-liver-organoids/338977/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":74,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/prediction-for-oxaliplatin-induced-liver-injury-using-patient-derived-liver-organoids/338977.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":136,"interactionType":137,"userInteractionCount":44},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"What problem does the study address regarding oxaliplatin treatment?","Question",{"text":146,"@type":147},"L-OHP-based chemotherapy can lead to liver injury that affects treatment outcomes, but accurate and reliable biomarkers to predict who is at risk have not been established.","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"How were the patient-derived liver organoids used in this study?",{"text":151,"@type":147},"Organoids were established from noncancerous liver tissues from 10 patients who received L-OHP-based chemotherapy and hepatectomy, and their in vitro responses were compared with clinical signs of liver injury.",{"name":153,"@type":144,"acceptedAnswer":154},"What key biological findings linked organoid responses to clinical liver toxicity?",{"text":155,"@type":147},"Organoids from patients with high-grade liver injury showed increased mitochondrial superoxide levels and decreased mitochondrial membrane potential after L-OHP exposure, whereas oxidative stress was not observed in organoids from low-grade injury patients.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":75},1790145842]